← Leaderboards
Chengcheng Zhang
Ut Southwestern Medical Center
$6,781,238
Attributed
$6,781,238
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $953.9K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,781,238 · 4
By mechanism
R01$6,000,011 · 3
K01$781,227 · 1
Top collaborators
No co-investigators on record.
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Jaehyup Kim$656,870
- Dian Cao$2,685,861
- Michael Lee$179,255
- Tracy M Diaz$86,337
- Ignacio I. Wistuba$32,209,830
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularRegulationReceptorSignal TransductionMalignant NeoplasmsProteinsImmuneTumorIn VitroCellsLeukocytesCancer TherapyFamilyExtracellularProgenitorLeukemiaSignal PathwayBaseMediatingStem CellsUp-RegulationNovel Therapeutic InterventionInositolBlocking Antibodies
Grant awards (20)
Reprogramming myeloid cells to inhibit cancer development$373,643
R01 · FY2025 · CA · contact PI
ITIM-receptors for cancer treatment$551,973
R01 · FY2024 · CA · contact PI
Reprogramming myeloid cells to inhibit cancer development$354,961
R01 · FY2024 · CA · contact PI
ITIM-receptors for cancer treatment$569,405
R01 · FY2023 · CA · contact PI
Reprogramming myeloid cells to inhibit cancer development$366,170
R01 · FY2023 · CA · contact PI
ITIM-receptors for cancer treatment$565,597
R01 · FY2022 · CA · contact PI
Reprogramming myeloid cells to inhibit cancer development$388,283
R01 · FY2022 · CA · contact PI
ITIM-receptors for cancer treatment$576,447
R01 · FY2021 · CA · contact PI
ITIM-receptors for cancer treatment$613,805
R01 · FY2020 · CA · contact PI
The role of inhibitory receptors in leukemia development$329,925
R01 · FY2017 · CA · contact PI
The role of inhibitory receptors in leukemia development$329,925
R01 · FY2016 · CA · contact PI
The role of inhibitory receptors in leukemia development$329,925
R01 · FY2015 · CA · contact PI
The role of inhibitory receptors in leukemia development$320,027
R01 · FY2014 · CA · contact PI
The role of inhibitory receptors in leukemia development$329,925
R01 · FY2013 · CA · contact PI
Expansion of hematopoietic stem cells by Angiopoietin-like 2$164,160
K01 · FY2010 · CA · contact PI
Expansion of hematopoietic stem cells by Angiopoietin-like 2$164,160
K01 · FY2009 · CA · contact PI
Expansion of hematopoietic stem cells by Angiopoietin-like 2$164,160
K01 · FY2008 · CA · contact PI
Expansion of hematopoietic stem cells by Angiopoietin-like 2$164,160
K01 · FY2007 · CA · contact PI
Expansion of hematopoietic stem cells by Angiopoietin-like 2$68,581
K01 · FY2006 · CA · contact PI
Expansion of hematopoietic stem cells by Angiopoietin-like 2$56,006
K01 · FY2006 · CA · contact PI